Skip to main content

Table 3 Adverse events during CCRT for the 90 patients in the CCRT + TME group (cases)

From: Surgery with versus without preoperative concurrent chemoradiotherapy for mid/low rectal cancer: an interim analysis of a prospective, randomized trial

Adverse event

NCI-CTC grade

0

1

2

3

4

Hematologic toxicity

 Anemia

87

3

0

0

0

 Thrombocytopenia

84

5

1

0

0

 Leukocytopenia

74

5

8

3

0

Non-hematologic toxicity

 Diarrhea

50

16

14

10

0

 Nausea/vomiting

62

18

10

0

0

 Stomatitis

80

10

0

0

0

 Abdominal pain

78

8

4

0

0

 Proctitis

58

16

16

0

0

Metabolic/laboratory abnormality

 AST/ALT elevation

82

6

2

0

0

 Bilirubin elevation

86

3

1

0

0

 Creatinine elevation

89

1

0

0

0

Radiation-related toxicity

 Hand-foot skin reaction

73

13

4

0

0

 Dermatitis

66

16

8

0

0

  1. AST, aspirate aminotransferase; ALT, alanine aminotransferase; NCI-CTC, National Cancer Institute Common Toxicity Criteria